• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about glp/1

    Recent news which mentions glp/1

    Why Hims & Hers Health Are Falling Monday
    Tickers HIMS NEWS
    Tags glp/1 HIMS Earnings
    From Benzinga
    Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites
    Tickers AZN JNJ LLY NEWS
    Tags Markets NVO FDA
    From Benzinga
    GLP-1 Boom Sparks Potential 'Bubble Effect,' Shrinking Competition In Big Pharma, Warns Deloitte: 'The Question Is...'
    Tickers KR LLY NEWS NVO
    Tags Benzinga glp/1 Health Care
    From Benzinga
    Eli Lilly Stock Jumps On Weight-Loss Pill Trial
    Tickers LLY NEWS
    Tags FDA Market News LLY
    From Benzinga
    Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows
    Tickers NVO
    Tags GLP/1 drugs wegovy Technicals
    From Benzinga
    LIVN Nutrition Launches First-Ever HMB Fruit Chews, Introducing a New Delivery Format to Support "Musclespan" and Healthy Aging
    Tags Muscle Loss Women Nutrition
    From PRLog
    Zepbound Put Eli Lilly On Top — Now Its Next Big Move Could Supercharge The Stock
    Tickers LLY
    Tags Market News LLY Expert Ideas
    From Benzinga
    McDonald's Just Got Hammered By Weight-Loss Drugs — Twice
    Tickers CMG DPZ LLY MCD
    Tags Market News Expert Ideas Redburn Atlantic
    From Benzinga
    Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan
    Tickers AMZN GLP LLY TDOC
    Tags Benzinga glp/1 Long Ideas
    From Benzinga
    Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
    Tickers AMGN LLY NVO
    Tags Long Ideas AMGN glp/1
    From Benzinga
    Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
    Tickers ASND NVO
    Tags glp/1 Benzinga Pro Project
    From Benzinga
    Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
    Tickers HIMS LLY NEWS NVO
    Tags why it's moving Benzinga glp/1
    From Benzinga
    Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
    Tickers VKTX
    Tags Health Care oral/2735 Trading Ideas
    From Benzinga
    EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
    Tickers AMGN AZN HRTS LLY
    Tags Large Cap weight/loss wegovy
    From Benzinga
    EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
    Tickers ABBV ALNY AMGN HRTS
    Tags Pro Project Sector ETFs Benzinga
    From Benzinga
    Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
    Tickers FIRE LLY NEWS NVO
    Tags weight loss drugs Pharmaceutical Global
    From Benzinga
    New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
    Tickers LLY NVO OZEM
    Tags NVO Market News Expert Ideas
    From Benzinga
    EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
    Tickers AMGN CHAT HIMS LLY
    Tags OZEM LLY Roundhill Investment
    From Benzinga
    Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
    Tickers A AVTR DHR LLY
    Tags Benzinga TMO Stories That Matter
    From Benzinga
    Gary Black Keeping Tabs On Oprah's Upcoming TV Special About Ozempic — 'Shame, Blame And The Weight Loss Revolution'
    Tickers LLY NEWS NVO TECH
    Tags General NVO Tech
    From Benzinga
    S&P 500 Sets Sights On 5,400, But Analyst Warns Of Imminent Market Volatility
    Tickers AI SPY TECH
    Tags SPY Analyst Note Analyst Ratings
    From Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.